A delivery strategy for rotenone microspheres in an animal model of Parkinson's disease
Authors:
- Huaqing LiuHLHuaqing Liu
- Wangwen GuWGWangwen Gu
- Zhou YanZYZhou Yan
- Zhenghong XuZXZhenghong Xu
- Yongxin YangYYYongxin Yang
- Xingzu ZhuXZXingzu Zhu
- Yaping LiYLYaping Li
- 1 February 2006
- journal article
- Published by Elsevier in Biomaterials
- Vol. 27 (6) , 937-946
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(d,l-lactide-co-glycolide) blend microspheres fabricated by spray dryingBiomaterials, 2004
- Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenoneExperimental Neurology, 2004
- Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein AggregationExperimental Neurology, 2003
- Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in ratsBehavioural Brain Research, 2002
- Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniquesJournal of Controlled Release, 2000
- In vitro and in vivo evaluation of PLAGA (50/50) microspheres containing 5-fluorouracil prepared by a solvent evaporation methodInternational Journal of Pharmaceutics, 1996
- Methamphetamine and dopamine neurotoxicity: differential effects of agents interfering with glutamatergic transmissionNeuroscience Letters, 1995
- Thermoanalysis of microspheresThermochimica Acta, 1995
- Environmental Risk Factors in Siblings With Parkinson's DiseaseArchives of Neurology, 1991
- Studies on the Respiratory Chain-linked Reduced Nicotinamide Adenine Dinucleotide DehydrogenaseJournal of Biological Chemistry, 1968